Fast-moving cholera outbreaks place unusual pressure on health services because case volumes, treatment intensity and access conditions can change within days. A useful supply plan therefore connects epidemiological assumptions with care pathways, facility capacity, transport conditions and replenishment options. It must make oral rehydration available close to affected communities while ensuring that referral sites can safely manage severe dehydration, collect specimens, maintain infection prevention controls and report stock movements without interruption.
Effective cholera kit planning is a coordinated process rather than a one-time purchasing exercise. Aid organizations should define scenarios, select protocol-aligned products, divide supplies into deployable modules and establish clear stock triggers before orders are released. Quantities should be reviewed with national health authorities and clinical leads, while packaging, shelf life, documentation and last-mile constraints are assessed with logistics teams. This approach keeps resources aligned with actual treatment capacity and allows kits to be adjusted as outbreak data become more reliable.
A fixed kit quantity can quickly become inadequate or excessive when the affected population, attack rate, severity profile or care-seeking pattern differs from the original estimate. Demand also varies by service level: community oral rehydration points primarily need simple rehydration and referral materials, while treatment units and centres require larger volumes of clinical consumables, intravenous fluids, monitoring items and support equipment. Scenario-based planning connects these different demands to realistic patient flows instead of treating every location as an identical delivery point.
Organizations should build at least a planning case and a surge case, then document the assumptions behind each one. Triggers such as rising weekly admissions, faster stock consumption, new geographic clusters or disrupted access should determine when the surge case is activated. The WHO’s 2020 cholera kit framework offers a useful reference structure: it is designed around an initial month of response for 100 cases and separates treatment, investigation, laboratory and hardware functions. Local plans must still be adapted to national protocols, existing assets and resupply reality.
The calculation should begin with a shared operational picture. Teams need population figures, recent suspected and confirmed case trends, expected severity distribution, age profile, displacement patterns, referral routes and the number of functional treatment sites. They should also identify what is already available at health facilities, central stores and partner warehouses. Counting only planned beds or reported cases can hide important constraints such as insufficient staff, limited safe water, damaged roads or a laboratory that cannot process additional specimens.
Assessment findings should be translated into a dated planning worksheet with named owners for epidemiology, case management, WASH, laboratory, procurement and logistics inputs. Every assumption needs a source, confidence level and review date so that quantities can be updated without rebuilding the calculation from the beginning. The worksheet should distinguish gross requirement, usable stock, confirmed inbound supply and the remaining procurement gap. It should also record whether stock is physically accessible, protocol-compliant and suitable for the intended care level, rather than assuming that all inventory can be used interchangeably.
Start with the population at risk and develop low, planning and surge estimates using the attack rates approved by the response’s epidemiology lead. Convert projected cases into care categories because patients managed with oral rehydration generate a different consumption profile from those requiring intravenous therapy and observation. Adjust the model for under-reporting, delayed care seeking, population movement and the period the stock must cover. Forecasts should be refreshed at an agreed cadence using actual admissions, severity data and geographic spread, with changes documented so procurement teams can understand why requirements increased or decreased.
Map each oral rehydration point, health post, cholera treatment unit and cholera treatment centre against its intended role, staffed capacity, opening schedule and referral link. A nominal bed count is not enough; verify water, sanitation, power, waste handling, trained personnel and storage space because these factors determine safe throughput. Assign each location a maximum practical caseload and a replenishment route, then compare projected demand with that capacity. Where the referral chain is weak, pre-position stabilization supplies and communication tools while response managers address transport, staffing or infrastructure gaps.
Calculate lead time from requisition approval to usable stock at the service point, not merely from supplier dispatch to national arrival. Include manufacturing, quality review, export documents, customs clearance, central receipt, repacking, onward transport and final acceptance. Seasonal roads, insecurity, border procedures, vehicle availability and fuel access may create different lead times for each district. Set a realistic resupply frequency for every route and identify alternatives such as regional staging, smaller vehicles or pre-approved air freight. The longer or less reliable the route, the more carefully buffer stock and reorder triggers must be calibrated.
Kit contents should follow the care delivered at each level and the clinical protocols authorized by the relevant ministry of health. Core categories generally include oral rehydration materials, intravenous therapy items for severe dehydration, protocol-approved medicines, diagnostic and specimen materials, basic patient-care equipment and records. Product selection must account for adult and pediatric needs, compatibility between components and the skills available at the destination. Sending advanced items without trained staff or supporting consumables creates nominal capacity rather than usable capacity.
Build the bill of materials at item and presentation level, recording unit of issue, pack size, approved substitute, storage condition and expected consumption driver. Each product should be linked to a task such as rehydrating a patient, establishing IV access, collecting a specimen or monitoring stock. This makes cholera treatment supplies easier to quantify and audit while preventing gaps between primary items and accessories. A clinical lead should approve the final list, and any substitution made during sourcing should undergo the same compatibility and protocol review before shipment.
ORS supply planning should translate projected mild and moderate cases into sachets, preparation containers, safe water requirements, cups, measuring tools and patient records. Include materials for immediate administration, short observation and referral, as well as clear preparation instructions in locally understood languages. Stock design should prevent partially opened cartons from being lost or mixed with non-response inventory. Oral rehydration points also need hand-hygiene materials, cleaning supplies, waste containers and communication equipment. The WHO’s guidance on oral rehydration salts supports oral glucose-electrolyte solution for dehydration in all but the most severe cases.
Severe-case modules should combine the intravenous fluids authorized by national treatment protocols with compatible infusion sets, cannulas in appropriate sizes, securement materials, IV stands, monitoring tools, gloves and sharps containers. Planners must calculate fluids and accessories together; an excess of bags is not clinically useful if cannulas or giving sets run out first. Pediatric sizes and difficult-access scenarios require specific review. Pack these materials for rapid replenishment at treatment units and centres, and keep heavy fluid cartons within safe manual-handling and transport limits when designing pallet and vehicle loads.
Medicines should be included only when they appear in current national or response-approved clinical guidance and can be prescribed by qualified personnel. Quantities need to reflect eligibility criteria rather than the total projected caseload, particularly for antibiotics or pediatric adjuncts. Specify formulation, strength, pack size, age suitability, dosing aids and acceptable alternatives to prevent unsafe substitutions. Pediatric modules may also require smaller cannulas, calibrated cups, age-appropriate monitoring tools and weight-based documentation. Separate medicines from general consumables during quality review so authorization, shelf life and storage requirements receive dedicated checks.
Diagnostic planning should separate rapid detection, specimen transport and confirmatory laboratory functions. Provide approved rapid diagnostic tests with timers, instructions, PPE, waste materials and recording forms, then match specimen containers, transport media, labels, cold-chain materials and request forms to laboratory procedures. Testing volumes should follow the surveillance strategy rather than attempting to test every patient without purpose. WHO’s cholera guidance notes that rapid diagnostic tests can support early outbreak detection, while confirmation requires laboratory methods such as culture or PCR. Coordinate supplies with laboratory capacity and specimen transport schedules.
Infection prevention and control materials must be planned as an operational system, not as an isolated carton of PPE. Patient flow, hand-hygiene points, cleaning routines, laundry, sanitation, waste segregation and staff safety all determine what is required. The quantity of these items is driven by shifts, procedures, cleaning frequency and facility layout as well as patient numbers. WASH and clinical teams should jointly review consumption assumptions so water containers, disinfectants, protective items and waste materials remain compatible with the site’s protocols and infrastructure.
Support items are part of the response’s functional capacity. Beds or cots, cholera beds where specified, buckets, privacy screens, lighting, registers, communications equipment and basic maintenance tools may be as important as clinical consumables at a newly opened site. Emergency cholera supplies should therefore be mapped to the tasks and zones they support, with clean and contaminated items packed separately where appropriate. Reusable equipment also needs a cleaning method, responsible owner and replacement plan, while hazardous products require safe storage and handling instructions.
Select PPE according to task-based risk assessments and national IPC guidance rather than issuing the same combination for every activity. Depending on the task, kits may require examination or heavy-duty gloves, aprons or gowns, boots, masks and eye protection, together with handwashing stations, soap or approved hand rub. Disinfection items should include the locally authorized product, measuring equipment, labelled preparation containers and job aids for correct concentration and contact time. Quantities must cover staff shifts, cleaners, waste handlers and visitors where applicable, with supervision and training planned alongside distribution.
Patient-care areas need washable surfaces or equipment, dedicated buckets and containers, safe excreta handling, accessible handwashing and a reliable cleaning schedule. Waste modules should include colour-coded or locally approved bags and bins, sharps containers, temporary storage materials and tools for safe internal movement. Add heavy-duty cleaning equipment, laundry supplies and protective items for cleaners, while avoiding products that the site cannot safely dilute or dispose of. Facility teams should define movement routes for patients, staff, supplies and waste before opening so equipment placement reinforces separation between lower-risk and contaminated zones.
Modular design allows supplies to follow the care pathway instead of forcing every destination to receive a complete central-level package. Cholera medical kits can be divided by community care, peripheral treatment, central treatment, investigation, laboratory and site hardware functions. Each module should have a clear purpose, capacity assumption, packing list and replenishment logic. Common items may be standardized, but modules should remain separable so a surge in one district does not require breaking down an entire package intended for another location.
Interfaces between modules are as important as their contents. Define which module provides shared items such as registers, waste materials, specimen transport containers or communication tools, and prevent duplicate assumptions. Use consistent module codes and version numbers so field teams can identify what they received and procurement teams can manage revisions. WHO’s six-kit structure provides a practical reference for treatment at community, peripheral and central levels, plus outbreak investigation, laboratory confirmation and temporary-care hardware; local configuration should reflect existing facilities, protocols and transport limits.
Community modules should support immediate oral rehydration, basic assessment, short observation, health communication and rapid referral. Pack them in quantities that community workers can carry, secure and replenish without opening large clinical cartons. Contents may include ORS, preparation and serving materials, registers, referral forms, hand-hygiene and cleaning items, waste bags and simple communication aids. Clearly state what the module does not support, especially intravenous treatment or unsupervised medicine use. Link every community point to a named higher-level facility, transport arrangement and stock reporting channel before deployment.
Peripheral modules should enable stabilization and protocol-defined treatment within the capacity of health posts or treatment units, while central modules should support higher-volume, continuous care at fully staffed centres. Both require balanced quantities of fluids, infusion accessories, monitoring items, patient-care equipment, IPC materials and documentation. Central sites may need more laboratory, pharmacy, power, water and ward-support capacity, but scale should follow staffed beds and expected throughput. Maintain separate replenishment packs for fast-moving items so teams do not repeatedly open complete modules merely to replace a single consumable category.
Investigation modules should support case verification, field data collection, rapid testing where authorized, specimen collection and safe transport. Laboratory modules need to match the receiving laboratory’s approved methods, equipment and quality procedures rather than assuming universal compatibility. Hardware modules may include tents or partitions, beds, lighting, water-storage and distribution items, sanitation components, waste infrastructure and basic tools for establishing a temporary care area. Assign technical owners to each module because installation, calibration, biosafety and maintenance requirements differ from those of routine consumables. Deployment should include instructions, checklists and responsible contacts.
Quantity calculations should combine projected cases, severity mix, per-patient or per-procedure consumption, operating days and site-specific wastage assumptions. Separate one-time setup items from recurrent consumables so expansion needs are not confused with routine replenishment. The model should also deduct usable stock and confirmed inbound quantities, while excluding expired, quarantined, inaccessible or incompatible inventory. Maintain calculations at pack level as well as unit level because procurement, transport and issue records operate through cartons, cases, pallets and kits rather than theoretical individual pieces.
Buffer stock is a risk control, not an arbitrary percentage applied to every item. Set it according to demand variability, lead-time uncertainty, product criticality, storage capacity and the consequences of a stockout. High-volume fluids may require a different strategy from small diagnostic items because weight, warehouse space and transport frequency shape what can be held locally. Review buffer assumptions whenever caseload, access or supplier performance changes, and place stock at the level where it can be reached before the service point exhausts its working inventory.
Create separate consumption lines for oral rehydration, intravenous therapy and medicines because each follows a different clinical driver. Multiply projected eligible cases by the protocol-based planning quantity, then add documented allowances for spillage, damaged packs or training where justified. Cross-check fluids against infusion sets and access devices, and medicines against eligible patient groups, formulations and prescriber capacity. Once services begin, compare forecast consumption with issues and actual use per admission. Investigate large differences promptly; they may reflect a changing severity profile, recording errors, leakage, inappropriate use or an incorrect original assumption.
Safety stock should cover a defined risk period, such as additional consumption during a case surge or the expected delay created by route disruption. Classify items by clinical criticality and replacement difficulty, then assign a higher protection level to products that cannot be substituted safely or sourced quickly. Avoid concentrating all contingency stock in one warehouse if access to that location can fail. Use regional or district layers where feasible, with release authority and transfer rules agreed in advance. Expiry risk, temperature control, security and handling capacity must remain part of the buffer decision.
Set the reorder point as expected consumption during the full replenishment lead time plus the approved safety stock. Use recent average daily consumption, but add a trend factor when admissions are growing rapidly. Reorder calculations should be visible at each service and storage level, with an alert generated early enough for approval, picking, transport and receipt. Define an emergency escalation threshold below the standard reorder point and identify who can authorize redistribution or expedited shipment. Review parameters weekly during an active outbreak, or more often when caseload and access are changing quickly.
Humanitarian medical procurement should convert the approved bill of materials into unambiguous specifications, supplier evidence and acceptance criteria. Product name alone is insufficient; buyers need formulation or material, size, sterility status, regulatory classification, pack configuration, shelf-life requirement, labelling language, storage condition and compatible accessories. A cross-functional review by clinical, quality and logistics teams should occur before purchase orders are issued. This prevents a commercially available item from being accepted even though it cannot be used under the response protocol or at the intended facility.
Quality controls should continue from supplier qualification through receipt at destination. Define which documents must be reviewed before shipment, which lots may be sampled or inspected and which discrepancies require quarantine or rejection. Use change-control rules for brands, manufacturing sites, specifications and pack sizes so substitutions are never made silently. The purchasing file should preserve approvals, certificates, inspection results, batch details and deviation decisions. For time-critical orders, teams may accelerate review steps, but they should not remove the evidence needed to protect patients and maintain traceability.
Every line item should have an approved specification and a minimum remaining shelf life calculated at the expected delivery date. Record manufacturer, country of origin, batch or lot number, manufacturing and expiry dates, and any serial numbers required for equipment. Labels must be legible and consistent with shipping and quality documents. Traceability should connect supplier records to warehouse receipt and onward issue, allowing affected stock to be located quickly if a recall or quality concern arises. Mixed lots within a carton or pallet should be identified clearly rather than discovered during field distribution.
Supplier review should cover legal status, authorized distribution rights, quality systems, relevant licenses, performance history and the ability to meet emergency timelines without changing approved sources. Verify product registrations, conformity documents, certificates of analysis where applicable, sterilization evidence and transport authorizations against destination-country requirements. Documents should be current, attributable to the offered product and consistent across manufacturer, catalogue number and production site. Procurement teams should also assess subcontractors and proposed logistics partners because gaps in storage, handling or documentation after manufacture can compromise an otherwise compliant product.
Pre-shipment and receipt checks should confirm seals, sterile barriers, carton condition, labelling, moisture protection and tamper evidence where relevant. Packaging must withstand the planned transport chain and be suitable for stacking, manual handling and last-mile vehicles. Verify temperature, light, humidity and ventilation requirements against warehouse and transit conditions, using monitoring devices when the product or quality plan requires them. Any damaged, wet, crushed, temperature-exposed or incorrectly labelled stock should be segregated pending quality assessment. Acceptance records should include photographs and lot details so supplier claims can be investigated without losing traceability.
Packing should reflect the order in which field teams will establish services and consume supplies. Group items by function, label the outer and inner packs consistently and include a protected packing list with module version, quantities, lot details and handling conditions. Heavy fluids, fragile diagnostics, hazardous chemicals and sterile consumables require different protection and placement. Keep each package within realistic lifting limits, and design pallet loads for the vehicles, doorways, storage areas and handling equipment available along the route.
Storage and distribution plans should specify responsible locations, stock status, issue method, delivery frequency and proof of receipt. Apply first-expiry-first-out where appropriate while respecting lot segregation and quarantine controls. Kits should not disappear into general inventory without a response code that preserves visibility. Before dispatch, confirm the destination is open, staffed and able to store and use the module. Route plans need alternates, communication checkpoints and procedures for failed delivery, partial receipt or damaged cargo so exceptions are managed without losing accountability.
Use a standard module code, colour cue where appropriate, destination, gross weight, package count and handling symbols on every outer package. Inner packs should carry the same module identity so contents remain recognizable after pallets are broken down. Place setup materials and instructions where they can be accessed first, and avoid combining chemicals with medicines or products that could be damaged by leakage. Include a concise checklist that lets the receiving team verify quantities without unpacking every sterile item. Version control is essential when kit contents change between procurement rounds.
Allocate deliveries to oral rehydration points, cholera treatment units and cholera treatment centres according to their service role, current admissions, stock on hand and resupply interval. Small community sites may need frequent manageable deliveries, while central centres can receive palletized loads if storage and handling capacity permit. Use route manifests that identify module codes, quantities, lots and responsible recipients. Coordinate arrival windows with facility teams and security or access actors. The final handover should record shortages, damage and temperature concerns immediately, followed by confirmation that critical items are available for use.
Maintain a simple reporting system that shows opening balance, receipts, issues, losses, closing balance, days of stock and inbound quantities by site. Focus reporting on critical tracer items while retaining full batch records in the inventory system. Establish thresholds for routine replenishment, urgent transfer and escalation, and name the person authorized to move stock between partners or districts. Reallocation decisions should compare caseload, usable balance, route time and minimum operating stock at both the sending and receiving sites. Document every transfer so batch traceability and donor accountability remain intact.
Common failures include ordering from a generic list without modelling cases, treating all facilities alike, overlooking accessories, and counting stock that is expired, inaccessible or incompatible. Teams may also underestimate the volume and weight of IV fluids, omit cleaning and waste materials, or send medicines without the required authorization and prescribing capacity. Another frequent error is building a kit around procurement convenience rather than patient flow, leaving community sites over-equipped while referral centres lack the items needed for severe cases.
Good planning also avoids silent substitutions, unclear module versions, unrealistic lead times and buffer percentages that have no documented rationale. Every kit should have an owner, intended care level, capacity assumption, replenishment trigger and reporting method. Conduct a tabletop review before dispatch by tracing a patient, a specimen and a stock request through the planned system. After deployment, collect consumption, loss, delivery and user feedback data. Updating the kit based on field evidence is essential; repeating the first packing list without review can reproduce the same operational gaps throughout the response.
Corena can support aid organizations by consolidating approved product lists across consumables, diagnostics, PPE, patient-care equipment and supporting materials. Its emergency response and aid operations can align sourcing and shipment preparation with urgent deployment schedules, while procurement teams retain responsibility for clinical protocols, quantities, destination requirements and final approvals. A shared specification matrix helps keep requested products, acceptable alternatives, documentation and delivery priorities consistent across multiple manufacturers and shipment lots.
For repeat or multi-country deployments, Corena’s medical supplies supply service can support manufacturer coordination, batch traceability, quality documentation, functional packing and export preparation. The most effective engagement begins with a version-controlled bill of materials, target delivery dates, minimum shelf life, consignee rules and acceptance criteria. This allows procurement and logistics activities to follow the response design while keeping substitutions and deviations visible for review. Local regulatory authorization, qualified clinical oversight and destination-level receipt controls should remain integrated throughout the process.
Corena is a global provider of Healthcare Solutions, offering pharmaceuticals, medical devices, dental, veterinary, and laboratory products. Since 2009, we have supported emergency response, rare disease treatments, and clinical trial supplies with reliable and customer-focused services.